Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria-Magdalena Balp

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Dermatology and Therapy|March 17, 2025
Cluster Analysis of Clinical Remission and Relapse Patterns in Chronic Urticaria: Results from the PREDICT-CU StudyMaria-Magdalena Balp, Irina Pivneva, Andrii Danyliv, et al.
JHEP Reports : Innovation in Hepatology|May 22, 2020
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosisLorraine McSweeney, Matthew Breckons, Gulnar Fattakhova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 8, 2020
Real-World Burden of Nonalcoholic SteatohepatitisAndreas Geier, Mary E Rinella, Maria-Magdalena Balp, et al.
The Patient|January 28, 2025
Assessing Preferences of Patients with Chronic Spontaneous Urticaria for Injectable Treatment ProfilesAna Maria Giménez-Arnau, Maria-Magdalena Balp, Andrii Danyliv, et al.
The World Allergy Organization Journal|November 28, 2022
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticariaMartin Metz, Jonathan A Bernstein, Ana M Giménez-Arnau, et al.
Dermatology and Therapy|October 27, 2022
Predicting Clinical Remission of Chronic Urticaria Using Random Survival Forests: Machine Learning Applied to Real-World DataIrina Pivneva, Maria-Magdalena Balp, Yvonne Geissbühler, et al.
Clinical and Translational Allergy|August 19, 2015
ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticariaKarsten Weller, Marcus Maurer, Clive Grattan, et al.
European Journal of Dermatology : EJD|January 31, 2019
The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study)Jean-Philippe Lacour, Abdallah Khemis, Françoise Giordano-Labadie, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Dermatology and Therapy|March 17, 2025
Cluster Analysis of Clinical Remission and Relapse Patterns in Chronic Urticaria: Results from the PREDICT-CU StudyMaria-Magdalena Balp, Irina Pivneva, Andrii Danyliv, et al.
JHEP Reports : Innovation in Hepatology|May 22, 2020
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosisLorraine McSweeney, Matthew Breckons, Gulnar Fattakhova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 8, 2020
Real-World Burden of Nonalcoholic SteatohepatitisAndreas Geier, Mary E Rinella, Maria-Magdalena Balp, et al.
The Patient|January 28, 2025
Assessing Preferences of Patients with Chronic Spontaneous Urticaria for Injectable Treatment ProfilesAna Maria Giménez-Arnau, Maria-Magdalena Balp, Andrii Danyliv, et al.
The World Allergy Organization Journal|November 28, 2022
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticariaMartin Metz, Jonathan A Bernstein, Ana M Giménez-Arnau, et al.
Dermatology and Therapy|October 27, 2022
Predicting Clinical Remission of Chronic Urticaria Using Random Survival Forests: Machine Learning Applied to Real-World DataIrina Pivneva, Maria-Magdalena Balp, Yvonne Geissbühler, et al.
Clinical and Translational Allergy|August 19, 2015
ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticariaKarsten Weller, Marcus Maurer, Clive Grattan, et al.
European Journal of Dermatology : EJD|January 31, 2019
The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study)Jean-Philippe Lacour, Abdallah Khemis, Françoise Giordano-Labadie, et al.
Pageof 6